7-48227272-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152701.5(ABCA13):āc.479A>Gā(p.Asn160Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000165 in 1,613,334 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152701.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ABCA13 | NM_152701.5 | c.479A>G | p.Asn160Ser | missense_variant | 6/62 | ENST00000435803.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ABCA13 | ENST00000435803.6 | c.479A>G | p.Asn160Ser | missense_variant | 6/62 | 1 | NM_152701.5 | P1 | |
ABCA13 | ENST00000417403.5 | c.479A>G | p.Asn160Ser | missense_variant, NMD_transcript_variant | 6/18 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000855 AC: 130AN: 152028Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000209 AC: 52AN: 249058Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135130
GnomAD4 exome AF: 0.0000944 AC: 138AN: 1461188Hom.: 1 Cov.: 32 AF XY: 0.0000688 AC XY: 50AN XY: 726896
GnomAD4 genome AF: 0.000848 AC: 129AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.000847 AC XY: 63AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.479A>G (p.N160S) alteration is located in exon 6 (coding exon 6) of the ABCA13 gene. This alteration results from a A to G substitution at nucleotide position 479, causing the asparagine (N) at amino acid position 160 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
ABCA13-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 28, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at